The National Science Foundation Awards Lura Health a $1M Phase II Small Business Innovation Research Grant

BOSTON--()--Lura Health, an innovative medical device company developing the first wearable salivary diagnostic health monitoring system, announced today that the National Science Foundation (NSF) has awarded the company a Phase II Small Business Innovation Research (SBIR Ph II) grant.

The SBIR Ph II grant is a 24-month, $1M award that will be used to complete research and development of the Lura Health monitoring system. This award will accelerate progress towards a regulatory submission and an expected market release in 2023.

We are very pleased to continue our cooperation with the National Science Foundation. The NSF is uniquely focused on bringing high-impact innovation to market, and supports startups addressing humanity’s most critical challenges. With this award, we are proud to join a cohort of diverse and prominent early-stage technology companies, and will benefit greatly from the network as we move toward commercialization.” - Daniel Weinstein, BSBME, CEO and cofounder.

This award brings Lura Health’s total funding amount to $2.5M and provides eligibility for an additional $500k in matching funds from the NSF. Lura Health is currently raising a series-seed financing round, expecting to close in Q2 2022.

Supporters of Lura Health include the National Science Foundation (NSF), SOSV, SOSV’s HAX, Dorm Room Fund (DRF), VentureWell, New England Medical Innovation Center (NEMIC). Additionally, cofounders Daniel Weinstein and Noah Hill were selected to the Forbes Under 30 Class of 2021 in the Manufacturing and Industry category.

About the NSF’s Small Business Programs

America’s Seed Fund powered by NSF awards $200 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $2 million in funding to support research and development (R&D), helping de-risk technology for commercial success. America’s Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $8.5 billion that supports fundamental research and education across all fields of science and engineering. For more information, visit seedfund.nsf.gov.

About Lura Health

Lura Health is an innovative medical device company developing the first wearable health salivary diagnostic monitoring platform. The company’s salivary diagnostic wearable sensors are positioned to help patients with chronic diseases, enabling them to continually monitor critical health markers in a non-invasive, minimally noticeable way. To learn more, visit www.LuraHealth.com.

Contacts

Daniel Weinstein
CEO & Co-founder, Lura Health
Daniel@LuraHealth.com

Release Summary

The National Science Foundation Awards Lura Health a $1M Phase II Small Business Innovation Research Grant to accelerate product development.

Contacts

Daniel Weinstein
CEO & Co-founder, Lura Health
Daniel@LuraHealth.com